Eledon Pharmaceuticals, Inc. - Common Stock —— 现金流量表 (NASDAQ:ELDN)

Financials

经营活动产生的现金 -15.21 M-28.91 M-28.42 M-39.53 M-47.27 M-62.34 M -68.89 M 投资活动产生的现金 11.04 M11.04 M—-45.29 M-70.31 M10.79 M 12.86 M 融资活动产生的现金 109.58 M-449 K-449 K33.02 M133.52 M53.81 M — 自由现金流 -15.21 M-28.91 M-28.42 M-39.53 M-47.27 M-62.34 M -68.89 M

新闻

Is BillionToOne, Inc. (BLLN) Stock Outpacing Its Medical Peers This Year?

EXCLUSIVE: NewcelX Eyes Accelerated 2026 Execution For Diabetes Drug - NewcelX (NASDAQ:NCEL)

Leerink Partners重申Eledon股票"跑赢大盘"评级,目标价5美元

Leerink Partners reiterates Outperform on Eledon stock at $5

Eledon报告胰岛移植试验中患者实现胰岛素独立

Eledon reports insulin independence in islet transplant trial

NewcelX与Eledon合作开发1型糖尿病疗法

NewcelX partners with Eledon on type 1 diabetes therapy

Eledon Pharmaceuticals at Guggenheim Summit: Tegoprubart’s Promising Path

Eledon公司报告tegoprubart肾移植24个月积极数据

Eledon reports positive 24-month kidney transplant data for tegoprubart

Eledon的tegoprubart在肾移植试验中显示出前景